Investors That Believe.
We are proud to be supported by several firms that believe in our mission of improving patient outcomes through regenerative medicine.
HighCape is a growth equity fund with a unique, multidisciplinary team of savvy executives. With decades of business success, HighCape transforms outstanding medical technology companies into sustainable businesses.
Deerfield works across the healthcare ecosystem, connecting people, capital, ideas, and technology in new, and often unexpected ways.
MidCap is led by a team of seasoned investment professionals that have managed credit portfolios through multiple credit cycles. Our decades of industry and credit market experience provides us with the ability to deftly assess and deliver customized financing needs for our portfolio companies.
Founded in 1962, the 501(c)(3) nonprofit organization now known as KeraLink International (previously Tissue Banks International) set the standard for addressing corneal blindness by establishing the largest network of quality eye banks in the United States, as well as numerous eye banks abroad. In 2019, KeraLink sold its eye bank network and is using the proceeds from the sale and its other resources to focus exclusively on addressing corneal disease and blindness in developing countries, where the need is most acute.
Click here to read the latest news about Aziyo Biologics.
Connect With Us
Stay up-to-date on our latest developments by connecting with us on LinkedIn.
Learn more about the people who make up our experienced leadership team.
Partner With Us
Interested in a partnership or have a question about investing?